Phase I/Ii Clinical Trial of Anti-Ox40, Radiation and Cyclophosphamide in Patients With Prostate Cancer: Immunological Analysis
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p255
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
BMJ